BRAF and colorectal carcinoma: In early-stage dMMR CRC, we found that 3 of 24 patients had a BRAF mutation, and in advanced-stage dMMR CRC, 2 of 19 patients had a BRAF mutation, corresponding to normal percentages of BRAF mutation (Supplementary Table 2).